Last reviewed · How we verify

NCT06985511

Assessment of Marginal Bone Loss and Anterior Implant Stability in Immediate Versus Early Implant Placement

Completed NA Last updated 22 May 2025
What this trial tests

NA trial testing Immediate implant placement in Marginal Bone Loss in 12 participants. Completed in 15 February 2024.

Timeline
10 January 2023
Primary endpoint
15 February 2024
15 February 2024

Quick facts

Lead sponsorYasser Ahmed
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment12
Start date10 January 2023
Primary completion15 February 2024
Estimated completion15 February 2024
Sites1 location across Lebanon

Drugs / interventions tested

Conditions studied

Sponsor

Yasser Ahmed

Who can join

Adults 20 to 40, any sex, with Marginal Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine the differences in implant stability and measurement of bone loss near implants between two different healing approaches used for teeth replacement in the front part of the upper jaw.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Immediate implant placement

Trials testing the same drug.

Other recruiting trials for Marginal Bone Loss

Currently open trials in the same condition.

Other Yasser Ahmed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06985511.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing